Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SmartCelle is Altus Formulation's proprietary polymeric micellar technology for parenteral, oral and topical delivery of insoluble molecules.
read more
STA Pharmaceutical, a subsidiary of WuXi AppTec, and Dizal Pharmaceutical have announced a strategic partnership.
read more
Sekisui Diagnostics Enzyme business announces the completion of a new BioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a $1.9 million investment.
read more
Cantargia and Patheon Biologics have signed an agreement regarding future production of the antibody CAN04 (nidanilimab).
read more
ICON has acquired a majority shareholding in MeDiNova Research, a site network with research sites in key markets in Europe and Africa.
read more
Tilray announced its wholly-owned subsidiary Tilray Portugal Unipessoal has received a standard manufacturing license and a GMP certification.
read more
Cadent Therapeutics today announced the receipt of the second milestone payment from Novartis following the initiation of a Phase 2 clinical study of MIJ821.
read more
Ubiquigent has entered into an agreement with Dorian Therapeutics to provide access to one of its novel small molecule libraries specifically designed to target deubiquitylase enzymes.
read more
Catalent is set to launch its new OneBio Suite for the integrated development, manufacturing, and clinical supply of biologic drugs.
read more
VAI has partnered with Adents to provide its pharmaceutical customers with a complete solution to meet upcoming requirements under the Drug Supply Chain Security Act (DSCSA).
read more
WuXi Biologics has entered into a strategic partnership LOI with a global vaccine leader, pursuant to which WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market.
read more
Particle Sciences has broadened its Drug Enforcement Administration (DEA) registration to become an authorized manufacturer of Schedule I substances.
read more
Epic Sciences has named Chockalingam "Palani" Palaniappan as its new CTO to help the company advance its Functional Cell Profiling technology to drive global expansion.
read more
Veratrak has announced that CPO Central Pharma has selected its platform to help it achieve digitized end-to-end visibility of its supply chain and improve collaboration.
read more
MMS Holdings announced the addition of Dr. Mike Poole, MD, FACP to its board of scientific advisors.
read more